SCHEMBL2597326

SCHEMBL2597326

CCC(Cl)OC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29101107 0.85 TSHR (0.33)
SCHEMBL609000 0.81 ALDH1A1 (0.35)
SCHEMBL638840 0.80
SCHEMBL892657 0.79
SCHEMBL609001 0.79
SCHEMBL10842062 0.77
SCHEMBL10919035 0.77
SCHEMBL10878549 0.77 CA2 (0.39)
SCHEMBL1818354 0.76
SCHEMBL9314301 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478391-B Ornidazole ester prodrug, pharmaceutical composition, and preparation method and application thereof 南京锐志生物医药有限公司 2023-09-15 CN claimed
CN-114436972-A Pabendazole derivative and preparation method and application thereof 山东大学 2022-05-06 CN claimed
CN-122070276-A Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same 人类生物科学股份有限公司 2026-05-19 CN disclosed
EP-4705289-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF Terran Biosciences Inc. (US) 2026-03-11 EP disclosed
US-12421260-B2 Neurokinin-1 antagonist SHANGHAI SHENGDI PHARMACEUTICAL CO., LTD (CN) 2025-09-23 US disclosed
US-20250206724-A1 SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2025-06-26 US disclosed
EP-4499612-A1 SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2025-02-05 EP disclosed
CN-118974020-A Substituted 3-aminoindazole derivatives as kinase inhibitors 内尔维亚诺医疗科学公司 2024-11-15 CN disclosed
CN-115677718-B Methyl methylamine derivative preparation, pharmaceutical composition and application thereof 武汉思瓴生物科技有限公司 2024-11-01 CN disclosed
WO-2024226691-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF TERRAN BIOSCIENCES INC. (US) 2024-10-31 WO disclosed
CN-114728883-B Ibuprofen ester prodrug, pharmaceutical composition, preparation method and application 南京海融医药科技股份有限公司 2024-07-12 CN disclosed
WO-2009115427-A1 PYRROLIDINYL DERIVATIVES AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2009-09-24 WO disclosed
EP-2074107-A2 TRICYCLIC COMPOUNDS AS MATRIX METALLOPROTEINASE INHIBITORS Wyeth a Corporation of the State of Delaware (US) 2009-07-01 EP disclosed
WO-2008057254-A2 TRICYCLIC COMPOUNDS AS MATRIX METALLOPROTEINASE INHIBITORS WYETH (US) 2008-05-15 WO disclosed
US-5120841-A Antibiotics for easy absorption TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-06-09 US disclosed
EP-0104984-B1 VINYLCARBAMIC ACID ESTERS AND THEIR PREPARATION SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1990-05-16 EP disclosed
EP-0128029-B1 CEPHALOSPORIN ESTER DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1989-02-08 EP disclosed
EP-0128029-A2 Cephalosporin ester derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1984-12-12 EP disclosed
EP-0104984-A2 Vinylcarbamic acid esters and their preparation SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1984-04-04 EP disclosed
US-4120888-A REACTING PHOSGENE WITH AN EPOXY MINEREC CORPORATION (US) 1978-10-17 US disclosed